Prevencio Awarded US, European, and Japanese Patents for HART CADhs, its AI-Driven Blood Test for Coronary Artery Disease

The newly issued patents strengthen Prevencio’s intellectual property portfolio and support its long-term strategy to expand HART CADhs adoption globally. HART CADhs is the only blood test that combines multiple cardiac proteins with machine learning to deliver a highly accurate, non-invasive diagnosis of obstructive CAD.